FOS and glycogen storage disease VI: This raises the possibility of AP-1 acting as a mediator of inappropriate chromatin remodeling and cellular activation/senescence in multiple cell types, with evidence from our analysis of persisting differential chromatin accessibility, gene expression signatures, and cell protein markers of activation that may contribute to both acute disease and post-COVID-19 syndrome.